vs
Side-by-side financial comparison of Civeo Corp (CVEO) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $151.7M, roughly 1.1× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -4.0%, a 11.8% gap on every dollar of revenue. On growth, Civeo Corp posted the faster year-over-year revenue change (7.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $14.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -1.4%).
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
CVEO vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $161.6M | $151.7M |
| Net Profit | $-6.5M | $11.8M |
| Gross Margin | 22.7% | 30.4% |
| Operating Margin | -0.1% | 20.4% |
| Net Margin | -4.0% | 7.8% |
| Revenue YoY | 7.1% | -41.1% |
| Net Profit YoY | 58.1% | -80.8% |
| EPS (diluted) | $-0.58 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $161.6M | $151.7M | ||
| Q3 25 | $170.5M | $267.8M | ||
| Q2 25 | $162.7M | $244.0M | ||
| Q1 25 | $144.0M | $211.8M | ||
| Q4 24 | $151.0M | $257.6M | ||
| Q3 24 | $176.3M | $78.8M | ||
| Q2 24 | $188.7M | $76.1M | ||
| Q1 24 | $166.1M | $67.5M |
| Q4 25 | $-6.5M | $11.8M | ||
| Q3 25 | $-455.0K | $55.4M | ||
| Q2 25 | $-3.3M | $-17.7M | ||
| Q1 25 | $-9.8M | $21.2M | ||
| Q4 24 | $-15.4M | $61.6M | ||
| Q3 24 | $-5.1M | $-8.8M | ||
| Q2 24 | $8.2M | $-364.0K | ||
| Q1 24 | $-5.1M | $-364.0K |
| Q4 25 | 22.7% | 30.4% | ||
| Q3 25 | 25.7% | 57.8% | ||
| Q2 25 | 25.3% | 51.2% | ||
| Q1 25 | 20.4% | 55.9% | ||
| Q4 24 | 18.6% | 55.0% | ||
| Q3 24 | 21.4% | 27.8% | ||
| Q2 24 | 25.4% | 29.7% | ||
| Q1 24 | 21.5% | 15.1% |
| Q4 25 | -0.1% | 20.4% | ||
| Q3 25 | 4.1% | 48.7% | ||
| Q2 25 | 1.7% | 13.8% | ||
| Q1 25 | -3.8% | 38.1% | ||
| Q4 24 | -6.7% | 44.4% | ||
| Q3 24 | 0.0% | 12.3% | ||
| Q2 24 | 6.9% | 7.0% | ||
| Q1 24 | -1.1% | 2.1% |
| Q4 25 | -4.0% | 7.8% | ||
| Q3 25 | -0.3% | 20.7% | ||
| Q2 25 | -2.0% | -7.3% | ||
| Q1 25 | -6.8% | 10.0% | ||
| Q4 24 | -10.2% | 23.9% | ||
| Q3 24 | -2.9% | -11.2% | ||
| Q2 24 | 4.4% | -0.5% | ||
| Q1 24 | -3.1% | -0.5% |
| Q4 25 | $-0.58 | $2.34 | ||
| Q3 25 | $-0.04 | $7.76 | ||
| Q2 25 | $-0.25 | $-2.95 | ||
| Q1 25 | $-0.72 | $3.33 | ||
| Q4 24 | $-1.04 | $11.56 | ||
| Q3 24 | $-0.36 | $-1.72 | ||
| Q2 24 | $0.56 | $-0.07 | ||
| Q1 24 | $-0.35 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.4M | $329.4M |
| Total Assets | $477.4M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $185.6M | ||
| Q3 25 | $12.0M | $166.0M | ||
| Q2 25 | $14.6M | $96.7M | ||
| Q1 25 | $28.4M | $84.7M | ||
| Q4 24 | $5.2M | $40.6M | ||
| Q3 24 | $17.9M | $46.9M | ||
| Q2 24 | $7.4M | $40.8M | ||
| Q1 24 | $16.8M | $30.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $43.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $174.4M | $329.4M | ||
| Q3 25 | $182.5M | $317.2M | ||
| Q2 25 | $209.4M | $235.3M | ||
| Q1 25 | $220.7M | $176.9M | ||
| Q4 24 | $236.4M | $132.4M | ||
| Q3 24 | $282.2M | $60.4M | ||
| Q2 24 | $297.4M | $62.7M | ||
| Q1 24 | $297.4M | $63.0M |
| Q4 25 | $477.4M | $918.5M | ||
| Q3 25 | $491.1M | $964.5M | ||
| Q2 25 | $508.8M | $841.0M | ||
| Q1 25 | $423.8M | $761.9M | ||
| Q4 24 | $405.1M | $655.3M | ||
| Q3 24 | $477.6M | $438.5M | ||
| Q2 24 | $483.2M | $422.4M | ||
| Q1 24 | $513.1M | $404.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $70.4M |
| Free Cash FlowOCF − Capex | $14.5M | $69.0M |
| FCF MarginFCF / Revenue | 8.9% | 45.5% |
| Capex IntensityCapex / Revenue | 3.0% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $70.4M | ||
| Q3 25 | $13.8M | $99.5M | ||
| Q2 25 | $-2.3M | $27.3M | ||
| Q1 25 | $-8.4M | $51.0M | ||
| Q4 24 | $9.5M | $54.0K | ||
| Q3 24 | $35.7M | $6.8M | ||
| Q2 24 | $32.4M | $13.3M | ||
| Q1 24 | $6.0M | $3.1M |
| Q4 25 | $14.5M | $69.0M | ||
| Q3 25 | $8.2M | $99.2M | ||
| Q2 25 | $-6.8M | $26.5M | ||
| Q1 25 | $-13.7M | $50.9M | ||
| Q4 24 | $1.8M | $-341.0K | ||
| Q3 24 | $28.2M | $6.2M | ||
| Q2 24 | $27.0M | $12.7M | ||
| Q1 24 | $372.0K | $2.3M |
| Q4 25 | 8.9% | 45.5% | ||
| Q3 25 | 4.8% | 37.0% | ||
| Q2 25 | -4.2% | 10.9% | ||
| Q1 25 | -9.5% | 24.0% | ||
| Q4 24 | 1.2% | -0.1% | ||
| Q3 24 | 16.0% | 7.8% | ||
| Q2 24 | 14.3% | 16.7% | ||
| Q1 24 | 0.2% | 3.4% |
| Q4 25 | 3.0% | 0.9% | ||
| Q3 25 | 3.3% | 0.1% | ||
| Q2 25 | 2.8% | 0.3% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 5.1% | 0.2% | ||
| Q3 24 | 4.2% | 0.8% | ||
| Q2 24 | 2.8% | 0.7% | ||
| Q1 24 | 3.4% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVEO
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
